Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
22 authors.
Hong Kai TeoDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0009-0006-2809-0230
Shuting HanDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-0217-7956
Thamizhanban ManoharanDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Yi RenDepartment of Otolaryngology, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-3809-0967
Cyrus Zai Ming ChengDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0009-0000-3235-4573
Soon Chai LooDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0009-0002-4004-043X
Zhewang LinDepartment of Biological Sciences, National University of Singapore, Singapore, Singapore.ORCID 0000-0003-1301-6661
Jiaqi LiDepartment of Biological Sciences, National University of Singapore, Singapore, Singapore.ORCID 0009-0004-0502-3313
Who-Whong WangDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.ORCID 0000-0002-8361-6761
Si-Lin KooDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Malini RethnamDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Choon Kong YapGenome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID 0009-0002-4024-2736
Bei-En SiewDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Gwyneth Shook-Ting SoonDivision of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.ORCID 0000-0001-5318-9327
Wai-Kit CheongDivision of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.
Kai-Yin LeeDivision of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.ORCID 0000-0003-0767-7922
Ian Jse-Wei TanDivision of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.ORCID 0000-0002-1923-0653
Bettina LieskeDivision of Colorectal Surgery, Department of Surgery, National University Hospital, Singapore, Singapore.ORCID 0000-0001-6221-3974
Ker-Kan TanDepartment of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Han Chong TohDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Iain Bee Huat TanDivision of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.ORCID 0000-0003-4951-0354
Gloryn ChiaDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-2099-719X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
A major challenge in advancing neoantigen-targeted therapies lies in the limited capacity of predicted neoantigens to robustly activate CD8
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Healthy donor T cell receptors expand functional neoantigen recognition beyond patient vaccination. · full record | OpenQuestion